Zyversa Therapeutics Stock Price on July 18, 2024
| ZVSA Stock | 1.23 0.08 6.96% |
If you're considering investing in ZyVersa Stock, it is important to understand the factors that can impact its price. As of today, the current price of ZyVersa Therapeutics stands at 1.23, as last reported on the 27th of December, with the highest price reaching 1.23 and the lowest price hitting 1.10 during the day. ZyVersa Therapeutics shows Sharpe Ratio of -0.0854, which attests that the company had a -0.0854% return per unit of risk over the last 3 months. ZyVersa Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out ZyVersa Therapeutics' Market Risk Adjusted Performance of (0.12), standard deviation of 8.12, and Mean Deviation of 4.03 to validate the risk estimate we provide.
At present, ZyVersa Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to 493.35, whereas Total Stockholder Equity is forecasted to decline to about 10.5 M. . At present, ZyVersa Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.08, whereas Price Earnings Ratio is forecasted to decline to (0.01). ZyVersa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
ZyVersa |
Sharpe Ratio = -0.0854
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ZVSA |
Estimated Market Risk
| 8.35 actual daily | 74 74% of assets are less volatile |
Expected Return
| -0.71 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ZyVersa Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ZyVersa Therapeutics by adding ZyVersa Therapeutics to a well-diversified portfolio.
Price Book 0.3836 | Book Value 27.331 | Enterprise Value -433.2 K | Enterprise Value Ebitda (2.21) | Shares Float 1 M |
ZyVersa Therapeutics Main Headline on 18th of July 2024
ZyVersa Therapeutics Announces Publication Demonstrating tha... by news.google.com
ZyVersa Therapeutics Announces Publication Demonstrating that Inflammasome ASC Inhibitor IC 100 Restored Retinal Structure and Function in a Retinopathy of Prematurity Animal Model StockTitan
ZyVersa Therapeutics Valuation on July 18, 2024
It is possible to determine the worth of ZyVersa Therapeutics on a given historical date. On July 18, 2024 ZyVersa was worth 4.33 at the beginning of the trading date compared to the closed value of 3.88. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ZyVersa Therapeutics stock. Still, in general, we apply an absolute valuation method to find ZyVersa Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ZyVersa Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ZyVersa Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 4.40 | 4.50 | 4.31 | 4.35 | 25,848 | |
07/18/2024 | 4.33 | 5.21 | 3.81 | 3.88 | 534,722 |
| 3.85 | 4.13 | 3.85 | 3.91 | 54,016 |
| Backtest ZyVersa Therapeutics | | | ZyVersa Therapeutics History | | | ZyVersa Therapeutics Valuation | Previous | Next |
ZyVersa Therapeutics Trading Date Momentum on July 18, 2024
| On July 19 2024 ZyVersa Therapeutics was traded for 3.91 at the closing time. The top price for the day was 4.13 and the lowest listed price was 3.85 . The trading volume for the day was 54 K. The trading history from July 19, 2024 was a factor to the next trading day price jump. The trading date delta against the next closing price was 0.77% . The trading date delta against the current closing price is 2.32% . |
ZyVersa Therapeutics Fundamentals Correlations and Trends
By evaluating ZyVersa Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ZyVersa Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ZyVersa financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ZyVersa Therapeutics Stock history
ZyVersa Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ZyVersa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ZyVersa Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ZyVersa Therapeutics stock prices may prove useful in developing a viable investing in ZyVersa Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 97.5 K | 59.6 K | |
| Net Loss | -12.7 M | -13.3 M |
ZyVersa Therapeutics Stock Technical Analysis
ZyVersa Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ZyVersa Therapeutics Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
ZyVersa Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ZyVersa Therapeutics December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how ZyVersa Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ZyVersa Therapeutics shares will generate the highest return on investment. By undertsting and applying ZyVersa Therapeutics stock market strength indicators, traders can identify ZyVersa Therapeutics entry and exit signals to maximize returns
ZyVersa Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ZyVersa Therapeutics' price direction in advance. Along with the technical and fundamental analysis of ZyVersa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ZyVersa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.72) | |||
| Total Risk Alpha | (0.98) | |||
| Treynor Ratio | (0.13) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for ZyVersa Stock analysis
When running ZyVersa Therapeutics' price analysis, check to measure ZyVersa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZyVersa Therapeutics is operating at the current time. Most of ZyVersa Therapeutics' value examination focuses on studying past and present price action to predict the probability of ZyVersa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZyVersa Therapeutics' price. Additionally, you may evaluate how the addition of ZyVersa Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |